β-Cyclodextrin-curcumin complex inhibit telomerase gene expression in T47-D breast cancer cell line

African Journal of Biotechnology

Volumn 10, Issue 83, 2011, Pages 19481-19488

  Kazemi, Fatemeh ^a,c   Zaraghami, Nosratollah ^a   Aval, Sedighe Fekri ^a   Monfaredan, Amir ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Anti cancer drug; Breast cancer; Drug delivery; Target therapy; Telomerase

Indexed keywords

BETA ACTIN; BETA CYCLODEXTRIN; CURCUMIN; DIMETHYL SULFOXIDE; MESSENGER RNA; TELOMERASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL VIABILITY; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; GENE; GENE EXPRESSION; GENE SEQUENCE; IC 50; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; TELOMERASE GENE;

CURCUMA LONGA;

EID: 84855801258     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: 10.5897/AJB11.1228     Document Type: Article

References (17)

1. Aggarwal BB, Sundaram C, Malani N, Ichikawa H (2007). Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 595: 1-75.
2. Ajaikumar B, Kunnumakkara P, Anand B, Aggarwal B (2008). Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Letters, 269: 199-225.
3. Anand P (2008). Biological activatives of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharma. 76: 1590-1611.
4. Cui SH (2006). Curcumin inhibits telomerase activity in human cancer cell lines. Int. J. Mol. Med. 18: 227-231.
5. Cui SX, Qu XJ, Xie YY, Zhou L, Nakata M, Makuuchi M, Tang W (2006). Curcumin inhibits telomerase activity in human cancer cell lines. Int. J. Mol. Med. p. 18.
6. Herbet B, Wright WE, Shaly J (2001). Telomerase and breast cancer. Breast cancer Res. 3(3): 146-149.
7. Hsina I, Sheua G, Chena H, Chiua L, Wange W, Chana H, Hsuc CH, Liang D (2010). N-acetyle cysteine mitigates curcumin-mediated telomerase inhibition through rescuing of SP1 reduction in A549 cells. Mut. Res. 688: 72-77.
8. Jurenka J (2009). Anti-inflammatory properties of curcumin, a major constituent of curcuma longa: A review of preclinical and clinical research. Alter. Med. Rev. 14(2): 141-152.
9. Kirkpatrick KL, Ogunkolade W, Elkak AE, Bustin S, Jenkins P, Ghilchick M, Newbold RF, Mokbel K (2003). hTERT expression in human breast cancer and noncancerous breast tissue: correlation with tumour stage and c-Myc expression. Breast Cancer Res. Treatment, 77: 277-284.
10. Murali MY, Jaggi S, Chauhan C (2010). β-Cyclodextrin-curcumin selfassembly enhances curcumin delivery in prostate cancer cells. Colloids and Surfaces B: Biointerfaces, 79: 113-125.
11. Nicole MB (2008). Targeting telomerase and telomeres with small molecule anti cancer compounds. MMG 445 Basic Biotechnol. J. 4: 72-79.
12. Rajeswari C, Alka A, Javed A, Khar RK (2005). Cyclodextrins in Drug Delivery: AAPS Pharm. Sci. Tech. 6(2): p. 43.
13. Sharma RA, Gescher AJ, Steward WP (2005). Curcumin: the story so far. Eur. J. Cancer, 41(13): 1955-1968.
14. Tarkanyi I, Aradi J (2008). Pharmacological intervention strategies for affecting telomerase activity. Future prospects to treat cancer and degenerative disease. Biochimie. 90: 156-172.
15. Tian N, Gaines WJ, Benjamin ZF (2010). Female breast cancer mortality clusters within racial groups in the United States. Health Place, 16: 209-218.
16. Vivek RY, Sarasija S, Kshama D, Seema Y (2009). Effect of Cyclodextrin Complexation of Curcumin on its Solubility and Antiangiogenic and Anti-inflammatory Activity in Rat Colitis Model. AAPS. Pharm. Sci. Tech. 10(3).
17. Vivek RY, Sahdeo P, Ramaswamy K, Jayaraj R, Madan MC, Lauri V, Jaakko P, Bharat BA (2010). Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through highercellular uptake. Biochem. Pharmacol. 80: 1021-1032.